Advertisement
Canada markets close in 1 hour 24 minutes
  • S&P/TSX

    21,861.21
    -150.51 (-0.68%)
     
  • S&P 500

    5,063.06
    -7.49 (-0.15%)
     
  • DOW

    38,442.29
    -61.40 (-0.16%)
     
  • CAD/USD

    0.7294
    -0.0026 (-0.36%)
     
  • CRUDE OIL

    82.79
    -0.57 (-0.68%)
     
  • Bitcoin CAD

    88,605.08
    -2,888.44 (-3.16%)
     
  • CMC Crypto 200

    1,397.93
    -26.17 (-1.84%)
     
  • GOLD FUTURES

    2,335.10
    -7.00 (-0.30%)
     
  • RUSSELL 2000

    1,991.00
    -11.64 (-0.58%)
     
  • 10-Yr Bond

    4.6580
    +0.0600 (+1.30%)
     
  • NASDAQ

    15,679.38
    -17.26 (-0.11%)
     
  • VOLATILITY

    15.90
    +0.21 (+1.34%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6822
    -0.0014 (-0.20%)
     

3 High-Risk, High-Reward Stocks to Add to Your Watch List

3 High-Risk, High-Reward Stocks to Add to Your Watch List

Most investors know that young biotech companies are risky investments. Between the unpredictable drug development process, the high costs of clinical trials, and fierce competition, many fledgling biotechs simply won't survive into adulthood. All three of the companies I'll discuss today are in the process of developing their first therapies and advancing them through clinical trials.